About NeuroStar
NeuroStar is a company based in Malvern (United States) founded in 2003.. NeuroStar has raised $118.69 million across 7 funding rounds from investors including Pfizer, General Electric and New Leaf Venture Partners. The company has 716 employees as of December 31, 2024. NeuroStar offers products and services including NeuroStar TMS System and NeuroStar Advanced Therapy. NeuroStar operates in a competitive market with competitors including Flow Neuroscience, Magstim, Soterix Medical, Neuroprex and NeuroQore, among others.
- Headquarter Malvern, United States
- Employees 716 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Neuronetics, Inc.
-
Annual Revenue
$74.89 M4.96as on Dec 31, 2024
-
Net Profit
$-43.71 M-44.78as on Dec 31, 2024
-
EBITDA
$-32.49 M-13.81as on Dec 31, 2024
-
Total Equity Funding
$118.69 M (USD)
in 7 rounds
-
Latest Funding Round
-
Investors
Pfizer
& 12 more
-
Employee Count
716
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of NeuroStar
NeuroStar is a publicly listed company on the NASDAQ with ticker symbol STIM in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of NeuroStar
NeuroStar offers a comprehensive portfolio of products and services, including NeuroStar TMS System and NeuroStar Advanced Therapy. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-invasive treatment using magnetic pulses for depression relief.
Adjunct treatment for OCD and anxious depression in patients.
Unlock access to complete
Unlock access to complete
Funding Insights of NeuroStar
NeuroStar has successfully raised a total of $118.69M across 7 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Last Round
-
First Round
First Round
(21 Aug 2009)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2020 | Amount | Debt – Conventional - NeuroStar | Valuation |
investors |
|
| Jun, 2017 | Amount | Series G - NeuroStar | Valuation | Ascension Ventures | |
| May, 2015 | Amount | Series C - NeuroStar | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NeuroStar
NeuroStar has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Pfizer, General Electric and New Leaf Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private debt investments are managed for middle-market companies.
|
Founded Year | Domain | Location | |
|
Strategic investments in healthcare technologies and data innovations.
|
Founded Year | Domain | Location | |
|
Early-stage US healthcare investments are made by Accuitive Medical Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NeuroStar
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NeuroStar
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neurostar Comparisons
Competitors of NeuroStar
NeuroStar operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flow Neuroscience, Magstim, Soterix Medical, Neuroprex and NeuroQore, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of a wearable device for stress and anxiety management
|
|
| domain | founded_year | HQ Location |
Neurotechnology solutions for EEG, TMS, and tDCS are developed.
|
|
| domain | founded_year | HQ Location |
Non-invasive neuromodulation devices for mood disorders are manufactured.
|
|
| domain | founded_year | HQ Location |
Wearable devices are developed to modulate tissues for neurological diseases.
|
|
| domain | founded_year | HQ Location |
Monophasic rTMS systems for depression treatment are developed by NeuroQore.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Neurostar
Frequently Asked Questions about NeuroStar
When was NeuroStar founded?
NeuroStar was founded in 2003 and raised its 1st funding round 6 years after it was founded.
Where is NeuroStar located?
NeuroStar is headquartered in Malvern, United States. It is registered at Malvern, Pennsylvania, United States.
Is NeuroStar a funded company?
NeuroStar is a funded company, having raised a total of $118.69M across 7 funding rounds to date. The company's 1st funding round was a Series C of $34.34M, raised on Aug 21, 2009.
How many employees does NeuroStar have?
As of Dec 31, 2024, the latest employee count at NeuroStar is 716.
What is the annual revenue of NeuroStar?
Annual revenue of NeuroStar is $74.89M as on Dec 31, 2024.
What does NeuroStar do?
NeuroStar was founded in 2003 and is headquartered in Malvern, United States. Operations center on the development of non-drug, non-invasive devices utilizing MRI-strength pulsed magnetic fields for neurorehabilitation. Therapeutic applications target central nervous system disorders, with TMS Therapy serving as an FDA-cleared option for adults with major depressive disorder who have not responded adequately to prior antidepressant treatments.
Who are the top competitors of NeuroStar?
NeuroStar's top competitors include Flow Neuroscience, Magstim and Neuroprex.
What products or services does NeuroStar offer?
NeuroStar offers NeuroStar TMS System and NeuroStar Advanced Therapy.
Is NeuroStar publicly traded?
Yes, NeuroStar is publicly traded on NASDAQ under the ticker symbol STIM.
Who are NeuroStar's investors?
NeuroStar has 13 investors. Key investors include Pfizer, General Electric, New Leaf Venture Partners, SLR Investment, and Ascension Ventures.
What is NeuroStar's ticker symbol?
The ticker symbol of NeuroStar is STIM on NASDAQ.